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Xiaobin Wu, Devis Sinani, Heejeong Kim, and Jaekwon Lee1
From the Redox Biology Center, Department of Biochemistry, University of Nebraska, Lincoln, Nebraska 68588-0664
Copper is an essential yet toxic trace element. The Ctr1 family
of proteins plays a critical role for copper uptake in eukaryotes.
However, the mechanisms of action of Ctr1 are largely
unknown. Our previous data demonstrated that copper transport induces conformational changes in the cytosolic C terminus of the yeast Saccharomyces cerevisiae Ctr1. To define the
physiological significance of this molecular event and gain better insights into the mechanism of Ctr1-mediated copper
uptake, we have characterized the functional roles of the Ctr1 C
terminus. A Ctr1 mutant lacking the entire C-terminal cytosolic
tail is functional in high affinity copper uptake; however, yeast
cells expressing this mutant are extremely sensitive to excess
copper. Toxic copper uptake is not attributed to elevated
expression or distinct subcellular localization of this mutant as
compared with wild type Ctr1. Further characterization of the
function of Ctr1 containing deletions or site-directed mutations
at the C terminus indicates a structural role for the C terminus in
controlling Ctr1 activities. In response to excess copper, Ctr1mediated copper transport is rapidly blocked in a C terminusdependent mechanism associated with direct binding of copper.
We propose that conformational changes in the cytosolic tail of
yeast Ctr1 by copper sensing within this domain lead to the inhibition of Ctr1-mediated copper transport. These data suggest a
new regulatory mechanism by which yeast cells maintain
homeostatic copper acquisition.

Copper functions in electron transfer reactions by virtue of
its ability to donate and accept electrons through redox reactions, which enables copper to act as a cofactor for vital
enzymes (1– 4). Serious defects in growth and development
from nutritional or genetic copper deficiencies indicate the
vital roles that copper plays in various physiological processes
(5–7). However, excess accumulation of copper is highly toxic
(8). Individuals diagnosed with Wilson disease experience
abnormal copper accumulation in the liver due to a defect in its
excretion, which in turn leads to hepatic dysfunction and neurological symptoms (6, 7).
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Identification and characterization of the molecular mechanisms involved in transport, distribution, and excretion of copper and also the regulation of these processes have revealed how
cells maintain homeostatic copper metabolism (3, 4). Ctr1
(copper transporter 1) serves as a high affinity copper transporter in the yeast Saccharomyces cerevisiae (9). This yeast also
expresses two additional Ctr1 family members, Ctr2 and Ctr3.
Ctr3 is functionally redundant to Ctr1; however, Ctr3 expression in many yeast strains is blocked by a transposon element
(10). Ctr2 appears to mobilize copper from the vacuole (11).
The Ctr1 family of copper transporters is conserved in
eukaryotes, including humans (3, 4). Ctr1 transports Cu⫹,
which is reduced by cell surface metalloreductases (12, 13), with
a Km of 1⬃5 M copper (9, 14). After copper is transported
across the cell membrane, it is incorporated into copper-requiring proteins via copper-delivery molecules and assembly
factors (15–17). Cytosolic copper chelators, such as metallothionein and phytochelatin, sequester excess copper (18, 19).
P-type ATPases play a role in copper detoxification by extruding cellular copper (6, 7).
Given that copper levels in the environment likely fluctuate
and excess copper is toxic, delicate control of copper uptake,
distribution, and detoxification is necessary for copper homeostasis. Transcriptional regulation of genes encoding components of copper transport and detoxification via Mac1 and Ace1
has been characterized in yeast (3, 22, 23). Moreover, excess
copper rapidly induces degradation of yeast Ctr1 (t1⁄2 ⬍ 30 min)
in the apparent absence of endocytosis (24). However, in contrast to these data, another group reported that when excess
copper is added to culture media, yeast Ctr1 is accumulated at
the vacuole in an Rsp5 ubiquitin ligase and endocytosis-dependent mechanism (25). Ctr1 that accumulates within the
vacuole is stable after 2 h. Two lysine residues (Lys-340 and
Lys-345) at the C terminus are necessary for copper-dependent
ubiquitination followed by the internalization of Ctr1 (25). This
mode of post-translational regulation of yeast Ctr1 appears to
occur in mammalian Ctr1 as well (26, 27), although other
research groups have reported contradictory data (28, 29). Collectively, the nature and mechanisms of copper-dependent
post-translational regulations of Ctr1 are not firmly established
yet in both yeast and mammals.
Ctr1 family members are integral membrane proteins possessing three predicted transmembrane domains (3, 4). Conserved methionine residues, one at the extracellular N terminus
and two that face into the periplasmic space in the predicted
second trans-membrane domain, are proposed to be involved
in copper translocation (30). However, overall sequence identity among Ctr1 family of proteins is minimal. In particular, the
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N-terminal extracellular domain and C-terminal cytosolic tail
are distinct in length and amino acid sequence. The predicted C
terminus of yeast Ctr1 and human Ctr1 encompass125 and 12
amino acids, respectively (3, 4). However, despite of this difference in length, many of Ctr1 family members possess potential
metal binding residues at the N and C termini. For instance, the
C-terminal cytosolic tail of yeast Ctr1 contains six Cys residues,
and human Ctr1 possesses His-Cys-His residues at the C terminus (3, 4). Several lines of evidence indicate that Ctr1 forms a
multimer complex (30 –32), and indeed a projection structure
of the human Ctr1 confirmed that Ctr1 forms a compact trimer
with a novel channel-like architecture and no structural occlusion of the predicted pore for copper (33). However, it is largely
unknown how Ctr1 transports copper. Our previous data demonstrate that copper induces conformational changes in the C
terminus of yeast Ctr1, which is coupled with copper transport
(34). Co-expression of Ctr1 monomers fused with either cyan
or yellow fluorescent protein resulted in fluorescence resonance energy transfer, which is consistent with multimer
assembly of Ctr1 in situ (34). Copper near the Km value of Ctr1
enhanced fluorescence resonance energy transfer in a manner
that correlated with cellular copper uptake, which revealed an
implication of structural remodeling of the C terminus in function and/or regulation of Ctr1 in yeast (34). Copper translocation through the transmembrane pore within a homotrimer
complex could culminate with a motion of the C terminus when
copper is released into the cytoplasm. Alternatively, structural
remodeling of Ctr1 could be implicated in regulation of Ctr1.
Given that Ctr1 in yeast and mammalian cells might undergo
copper-induced endocytosis and degradation (24 –27), a
specific conformation induced in response to excess copper
may recruit the machinery for internalization and degradation of Ctr1. It is also possible that the conformational
change in the cytosolic C terminus controls the copper
translocation across the transmembrane pore when cells
accumulate sufficient copper.
To gain better insights into the mechanisms of action and
regulation of Ctr1 and the physiological significances of the
conformational changes in the C terminus (34), we have characterized the functional roles for the C terminus of Ctr1 in yeast
S. cerevisiae. Cells expressing Ctr1 lacking the entire C-terminal tail are active in high affinity copper uptake but extremely
sensitive to excess copper. The yeast Ctr1 with serial deletion or
site-directed mutations of residues within the C terminus indicates that in response to excess copper, the C terminus rapidly
blocks Ctr1-mediated copper uptake with no significant
changes in expression levels and subcellular distribution of
Ctr1. Our data suggest a new regulatory mechanism of Ctr1 by
which yeast cells prevent toxic accumulation of copper.

EXPERIMENTAL PROCEDURES
Strains, Media, and Growth Conditions—A BY4741 haploid
S. cerevisiae strain (MATa his3⌬1 leu2⌬0 met15⌬0 ura3⌬0), in
which the Ctr1 gene is deleted (ctr1::kanMX4) and the Ctr3
gene is silent (Open Biosystems), was used in this study. Drs.
Bruno André (Université Libre de Bruxelles), Caroline Philpott
(National Institutes of Health), and David Eide (University of
Wisconsin-Madison) kindly provided rsp5/npi1 (35), end4-1
FEBRUARY 13, 2009 • VOLUME 284 • NUMBER 7

(36), and chc1-1 (37) strains and their isogenic wild type strains.
In the rsp5/npi1 strain, expression of Rsp5/Npi1 is reduced
⬎10-fold compared with isogenic wild type cells as a result of
the insertion of a Ty1 element in its 5⬘ region (35). end4-1 and
chc1-1 are temperature-sensitive mutant alleles (36, 37). Yeast
cells were cultured with synthetic complete (SC)2 media (2%
dextrose, 0.2% amino acid mixture, 0.67% yeast nitrogen base)
lacking uracil for plasmid selection (SC-ura) or YPD (2% dextrose, 2% Bacto-peptone, 1% yeast extract) media. Solid media
was prepared with the supplementation of 1.5% agar. Cell
growth on non-fermentable carbon sources was tested using
YPEG media (2% Bacto-peptone, 1% yeast extract, 2% ethanol,
3% glycerol, 1.5% agar). Yeast cells were cultured in SC-ura
media at 30 °C if no media or temperature is specified.
Plasmid Construction and Manipulation—If no expression
vector is indicated, single copy yeast vectors (p416-TEF) (38)
were used for a TEF2 gene promoter-driven constitutive
expression. For triple hemagglutinin (HA) epitope-tagging at
the N-terminal extracellular domain, a NotI restriction enzyme
site was created between the 119th and 120th amino acid. Sitedirected mutagenesis was conducted by the primer overlap
extension method (39). Serial truncation of the C terminus was
made by the PCR method. Common molecular biology techniques, including plasmid amplification and purification using
Escherichia coli, followed previously established methods (40).
All constructs were sequenced to confirm mutations and inframe fusion. Plasmid transformation into yeast was performed
using the lithium acetate method (41).
Cell Growth Assays—The functionality of Ctr1 mutant alleles
was determined by assessing the complementation of the
growth defect of ⌬ctr1 cells on YPEG media. Cells transformed
with Ctr1 plasmid were cultured to mid-log phase in SC-ura
media. Cells (5 l diluted at 0.1 optical density at a wavelength
of 600 nm (A600 ⫽ 0.1)) were spotted on solid YPEG media. To
further deplete copper in this media, we supplemented copper
chelator bathocuproine disulfonate (BCS) (20 or 50 M). Plates
were incubated at 30 °C for 3 days before photography. To
determine copper toxicity conferred by the Ctr1 mutant alleles,
cells were spotted on SC-ura media supplemented with copper
(CuCl2) at concentrations indicated in figures. Cell growth was
assessed after 1 day. Each assay was repeated at least two times
to confirm results.
Western Blot Analysis—Total protein extracts were prepared
by breaking cells with glass beads in phosphate-buffered saline
(PBS) containing protease inhibitor mixture (Complete Mini,
Roche Applied Science) and 1% Triton X-100. Protein concentrations were measured using a BCA kit (Pierce) according to
the manufacturer’s specifications. Cell lysates were denatured
in a SDS sample buffer containing dithiothreitol (100 mM) for
15 min at 60 °C, resolved by SDS-PAGE, and then transferred to
a nitrocellulose membrane. HA epitope-tagged Ctr1 was
detected by chemiluminescence using anti-HA antibodies
(Rockland) and horseradish peroxidase-conjugated anti-rabbit
IgG antibodies (Santa Cruz). Phosphoglycerate kinase (PGK)
2

The abbreviations used are: SC, synthetic complete; BCS, bathocuproine
disulfonic acid; GFP, green fluorescent protein; HA, hemagglutinin; PBS,
phosphate-buffered saline; SOD1, Cu,Zn superoxide dismutase.
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was probed as a loading control using anti-PGK antibodies
(Molecular Probes) and horseradish peroxidase-conjugated
anti-mouse IgG antibodies (GE Healthcare).
64
Cu Uptake Assays—Radioactive 64Cu (specific activity of
15–30 mCi/g of CuCl2) (Isotrace Technique) was added to
exponentially growing cells to the indicated concentrations,
and then the cells were incubated for 10 min (for determining
copper transport kinetics) or 5 min (for other copper uptake
assays) at room temperature. 64Cu uptake into cells was
quenched with ice-cold PBS containing 10 mM EDTA. These
cells were filtered using nitrocellulose membranes (0.22 m,
Millipore) and washed twice with PBS containing 10 mM
EDTA. Cell-associated 64Cu was quantified using a ␥-counter
(PerkinElmer Life Sciences 1470 WIZARD). 64Cu levels in
⌬ctr1 cells expressing an empty vector (Ctr1-independend
background uptake) were subtracted. Copper uptake was calculated using a standard curve and then normalized to the cell
number. Apparent Vmax and Km were determined via extrapolation to zero in the reciprocal plot for velocity versus copper
concentration using GraphPad PRISMTM software.
Subcellular Fractionation—Subcellular fractionation was
performed essentially as described previously (42) with the following modification. Exponentially growing cells were precultured with cycloheximide (100 g/ml) for 30 min and then cultured with or without copper supplementation (0.1 mM CuCl2,
30 min). Metabolic inhibitors (10 mM sodium azide and potassium fluoride) were added to cells, and then cells were collected
by centrifugation. Cells were washed 1 time with a breaking
buffer (10 mM Tris-HCl (pH 7.6), 10% sucrose, 10 mM EDTA,
and protease inhibitor mixture (Complete Mini, Roche Applied
Science)). Cells were then vortexed with glass beads. After centrifugation for 3 min at 300 ⫻ g, the supernatant (0.5 ml) was
loaded onto a linear sucrose gradient prepared by subsequently
layering 10, 20, 35, or 60% sucrose to form an 9-ml step gradient. Samples were subjected to centrifugation (at 4 °C at 50,000
rpm for 14 h). Fractions (500 l each) were collected from the
top of the gradient. Aliquots of each fraction were denatured in
an SDS sample buffer containing dithiothreitol (100 mM) at
60 °C for 15 min. HA-tagged Ctr1 in these fractions was
detected by Western blotting using anti-HA antibodies.
Lethality Assays—rsp5/npi1 (35), end4-1 (temperature-sensitive mutation of end4) (36), and chc1-1 (temperature-sensitive mutation of chc1) (37) strains and their isogenic wild type
strains were transformed with expression constructs of wild
type Ctr1 or Ctr1 with C-terminal 106 amino acid deletion
(Ctr1(300)). rsp5/npi1 cells grown to mid-log phase were cultured with and without supplementation of copper (CuCl2) at
concentrations indicated in the figures (see Fig. 5, E and F) for
1 h at 30 °C. For experiments using temperature-sensitive
end4-1 and chc1-1 mutant strains, cells were cultured at 25 °C
and then shifted to a restrictive temperature (37 °C) for 30 min
before adding copper to culture media. After culturing the cells
with copper for 1 h, they were washed twice and diluted to the
same cell density (A600 ⫽ 0.001), and then 100 l were plated on
solid YPD media. Our assumption is that cells accumulate toxic
copper and/or are severely damaged during the culture in
media supplemented with copper and are not able to grow on
YPD plates. After 2 days, the colonies that had grown were
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FIGURE 1. Functionality of Ctr1 lacking the C-terminal cytosolic tail.
A, schematic depiction of Ctr1 in yeast S. cerevisiae. The dotted line indicates
the predicted C-terminal tail encompassing amino acids 301– 406. White rectangles indicate three transmembrane domains. B–E, empty vector, fulllength Ctr1, or Ctr1 lacking its last 106 amino acids (Ctr1(300)) were expressed
in a ⌬ctr1 strain, and then cellular copper metabolism was examined.
B, Ctr1(300) functionally complements the growth defect of ⌬ctr1 cells on
non-fermentable (YPEG) media. Exponentially growing cells (5 l, diluted to
A600 ⫽ 0.1) were spotted on YPEG media supplemented with BCS copper
chelator. Cell growth was assessed after 3 days. C, cytosolic fractions were
subjected to activity assays for copper- and zinc-containing SOD1. D, 64Cu
uptake assays. Cells cultured in SC-ura and supplemented with copper chelator BCS (10 M for 12 h) were washed twice with prewarmed SC-ura media
and re-suspended in the same media. Cells were incubated with 64Cu (0.1 M
64
CuCl2) for 5 min. Cell-associated 64Cu was measured using a ␥-counter.
E, cells expressing Ctr1(300) are hypersensitive to copper. Exponentially
growing cells (5 l of cells diluted to A600 ⫽ 0.1) were spotted on SC-ura media
and supplemented with indicated concentrations of copper (CuCl2) (Cu).
Plates were incubated at 30 °C for 1 day, and cell growth was assessed. Each
bar in C and D represents the average ⫾ S.D. of at least four independent
experiments. *, p ⬍ 0.01, Student’s t test.

counted, and colony numbers were then compared with those
of control plates.
Superoxide Dismutase Activity Assays—Cell lysates were prepared by breaking cells with glass beads in PBS containing protease inhibitor mixture (Complete Mini, Roche Applied Science). We first inactivated manganese-containing superoxide
dismutase as described previously (43) and then measured copper and zinc-containing superoxide dismutase (SOD1) activities by determining the inhibition of nitrite formation from
hydroxylamine in the presence of superoxide anion generator
(44). SOD1 activities were normalized by protein concentrations and then converted to units using a standard curve of
bovine liver SOD1 (Sigma).

RESULTS
C-terminal Cytosolic Tail of Ctr1 Is Dispensable for Copper
Transport—To determine the roles for the cytosolic C-terminal
tail of Ctr1 in copper transport, we examined functionality of
Ctr1 with deletion of the C terminus encompassing the last 106
amino acids (Ctr1(300)) (Fig. 1A). ⌬ctr1 cells were not able to
grow on the YPEG media containing solely non-fermentable
carbon sources because of the defect in copper-requiring cytochrome c oxidase (Fig. 1B). However, the expression of either
full-length Ctr1 or Ctr1(300) complemented the growth defect
of ⌬ctr1 cells on YPEG media and the same media supplemented with BCS copper chelator that reduces bio-available
copper (Fig. 1B). No difference in growth was observed between
cells expressing either Ctr1 or Ctr1(300), which suggests that
VOLUME 284 • NUMBER 7 • FEBRUARY 13, 2009
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the C terminus of Ctr1 does not play a critical role in copper
transport followed by its insertion into cytochrome c oxidase.
Next, we measured the activities of copper-containing SOD1 in
these cells. Although SOD1 activities in ⌬ctr1 cells were hardly
detectable, the expression of either Ctr1 or Ctr1(300) dramatically enhanced SOD1 activities (Fig. 1C). Interestingly, cells
expressing Ctr1(300) exhibited higher SOD1 activities when
compared with cells expressing the full-length Ctr1 (Fig. 1C).
To directly monitor Ctr1 and Ctr1(300)-mediated cellular copper acquisition, we measured radioactive 64Cu uptake into cells.
Cells were cultured to exponential growth phase in SC media
supplemented with copper chelator BCS (10 M) for 12 h, and
then 64Cu (0.1 M, 64CuCl2) uptake was measured for 5 min.
Cellular 64Cu uptake was also higher in cells expressing
Ctr1(300) when compared with cells expressing Ctr1 (Fig. 1D).
Collectively, these data suggest that the C-terminal tail of Ctr1
is dispensable for high affinity uptake and subsequent distribution of copper to copper-requiring proteins.
Cells Expressing Ctr1 with a C Terminus Deletion Are Hypersensitive to Copper—Given that Ctr1(300) transports more copper as compared with Ctr1, we hypothesized that the C terminus may play a regulatory role in copper transport. We tested
this hypothesis by monitoring cell growth on media containing
toxic copper. ⌬ctr1 cells transformed with an empty vector,
Ctr1, or Ctr1(300) were cultured to mid-log phase, and then
cells (5 l cells diluted to A600 ⫽ 0.1) were spotted on SC media
supplemented with excess copper. Indeed, cells expressing
Ctr1(300) are extremely sensitive to copper. Although cells
expressing empty vector or Ctr1 grow on media containing 2
mM copper, cells expressing Ctr1(300) could not grow even on
media containing 0.1 mM copper (Fig. 1E). These cells were also
hypersensitive to silver but not other metals tested, including
zinc, iron, or cadmium (data not shown). Given that both Cu⫹
and Ag⫹ have been proposed as substrates of Ctr1 (14), these
data suggest that Ctr1(300) transport excess copper when cells
grow in high copper concentration media and that C terminus
may contain a regulatory domain preventing excess copper
uptake.
Mapping of the C Terminus to Identify Residues That Play
Regulatory Roles—To identify residues within the Ctr1 C terminus that play inhibitory roles in copper transport in response
to excess copper, we mapped the C terminus of Ctr1. Expression vectors of Ctr1 mutants with serial deletion of the C terminus were constructed (Fig. 2A) and then transformed into a
⌬ctr1 strain. Cell growth on both SC media containing excess
copper and copper-requiring YPEG media was then assessed
(Fig. 2B). BCS copper chelator was supplemented to YPEG
media to further deplete bio-available copper. Growth defects
on the YPEG media of cells expressing Ctr1 with the deletion of
the last 116 or 124 amino acids (Ctr1(290) or Ctr1(282)) suggested the non-functionality of these Ctr1 alleles in high affinity
copper transport. Cells that express Ctr1 with the deletion of
the last 6 amino acids (Ctr1(400)) showed slight but significant
copper sensitivity on SC media containing excess copper when
compared with cells expressing the wild type Ctr1. Cells
expressing Ctr1 with deletion of the last 12 amino acids
(Ctr1(394)) or additional amino acids up to 110 amino acids
(Ctr1(296)) are extremely sensitive to copper. ComplementaFEBRUARY 13, 2009 • VOLUME 284 • NUMBER 7

FIGURE 2. Growth assays of cells expressing Ctr1 with deletions or sitedirected mutations within its C terminus. A, C-terminal (amino acids 282–
406) sequence of yeast Ctr1. Truncations are indicated by the number of
amino acid residues. Amino acid residues that were subjected to site-directed
mutagenesis in this and subsequent figures are in bold type. B, empty vector,
full-length Ctr1, and Ctr1 with serial deletions of the C terminus or substitutions of Leu-397 and Leu-398 residues to Ala (Ctr1(L397A,L398A)) were
expressed in a ⌬ctr1 strain. Exponentially growing cells were diluted (A600 ⫽
0.1), and then cells (5 l) were spotted on non-fermentable (YPEG) or uracildeleted synthetic complete (SC-ura) media supplemented with indicated
concentrations of copper (CuCl2) or copper chelator BCS. Cell growth was
assessed after 1 and 3 days for SC-ura and YPEG media, respectively.

tion of growth defects of ⌬ctr1 cells on copper-requiring YPEG
media indicates that these Ctr1 alleles are fully functional in
copper uptake.
Mapping of the C terminus suggests that the amino acids
between 395 and 400 may contain important residues for the
regulation of homeostatic acquisition of copper. This domain
contains a dileucine motif (Fig. 2A) that is known to play a
role in internalization of membrane protein in mammalian
cells (31). Although the function of this motif in yeast S. cerevisiae has not been established, a regulatory role of a
dileucine motif in the yeast Gap1 amino acid permease was
suggested (35). To examine the roles for this motif in Ctr1 function and regulation, we substituted dileucine residues to alanine
(Ctr1(L397A,L398A)), expressed this mutant in a ⌬ctr1 strain,
and then tested cell growth on copper-requiring or toxic copper
media. This Ctr1 allele complemented growth of ⌬ctr1 cells on
YPEG media; however, cells expressing this mutant are
extremely sensitive to copper toxicity (Fig. 2B). This suggests an
important role for these leucine residues in the regulation of
Ctr1-mediated copper transport. When cellular copper is in
excess, the C terminus might regulate subcellular localization
and/or expression of Ctr1 or play a structural role for controlling copper transport activities of Ctr1 multimer complexes.
Epitope Tagging at the N or C Terminus Further Suggested
Critical Roles for the C Terminus in Preventing Copper Toxicity—
To determine the role of the C terminus in expression levels
and subcellular localization of yeast Ctr1, we have made
epitope-tagged Ctr1 constructs. Given that previous reports
used the Ctr1 allele fused with either single c-Myc at an EcoR1
site encompassing amino acids 382, 383, and 384 at the C terminus (Ctr1-Myc) (24) or GFP at the end of the C terminus
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 3. Expression levels of Ctr1 possessing C-terminal deletion or
mutation. A, functionality of Ctr1 fused with epitopes or GFP. GFP coding
sequence was inserted into a NotI site generated by PCR at the end of C
terminus. Single c-Myc epitope was inserted into the EcoRI site within the
C-terminal tail. Triple HA epitopes were inserted into a NotI site generated by
PCR after the 119th amino acid residue of wild type Ctr1, Ctr1(300), Ctr1(394),
and Ctr1(L397A,L398A). An empty vector, intact Ctr1, and epitope or GFPfused Ctr1 were expressed in a ⌬ctr1 strain. Exponentially growing cells in
synthetic complete media omitting uracil (SC-ura) were diluted (A600 ⫽ 0.1),
and then cells (5 l) were spotted on solid non-fermentable (YPEG) or SC-ura
media supplemented with indicated concentrations of copper (CuCl2) or copper chelator BCS. Cell growth was assessed after 1 and 3 days for SC-ura and
YPEG media, respectively. B, 64Cu uptake assays. Cells cultured in SC-ura
media containing copper chelator BCS (10 M for 12 h) were washed twice
with prewarmed SC-ura media and resuspended in the same media. Cells
were incubated with 64Cu (0.1 M 64CuCl2) for 5 min. Cell-associated 64Cu was
measured using a ␥ counter. Data represent the average ⫾ S.D. of three independent experiments. C, HA-epitope tagged full-length Ctr1 (Ctr1–3HA) or
Ctr1 with a truncation of the last 106 amino acids at the C terminus (HACtr1(300)) were expressed in a ⌬ctr1 strain. Exponentially growing cells were
cultured with or without supplementation of copper (CuCl2, 100 M) for 30
min. Cycloheximide (100 g/ml) was added to the cell culture 30 min prior to
copper supplementation. Total protein extracts were subjected to Western
blot analysis using anti-HA antibodies. PGK, phosphoglycerate kinase.
D, ⌬ctr1 cells expressing HA-tagged Ctr1, Ctr1(300), Ctr1(394), and
Ctr1(L397A,L398A) were cultured in media supplemented with (⫹) or without
(⫺) copper (CuCl2, 25 M) for 12 h. Total protein extracts were subjected to
Western blot analysis using anti-HA antibodies. Experiments were conducted
three times, and a representative figure is presented. Expression levels were
quantified using phosphoglycerate kinase loading control and then normalized to wild type Ctr1.

(Ctr1-GFP) (25), we expressed these constructs in ⌬ctr1 yeast
cells and then tested cell growth on non-fermentable YPEG
media and synthetic complete SC media. Both Ctr1-Myc and
Ctr1-GFP functionally complement growth defect of ⌬ctr1
cells on YPEG media (Fig. 3A, upper panel), suggesting similar copper transport activities of these alleles to that of nontagged Ctr1. However, cells expressing Ctr1-GFP or Ctr1-Myc
are extremely sensitive to copper when grown on SC media
(Fig. 3A, upper panel). This data suggests that structural perturbation of the C terminus of yeast Ctr1 confers copper sensitivity when expressed in yeast cells.
For epitope tagging at the N terminus, a NotI restriction
enzyme site was artificially generated directly after the start
codon or at several locations within the extracellular N terminus. Triple HA epitope was inserted into the NotI site, and then
the functionality of the Ctr1 fused with HA was tested. Among
these fusion proteins, Ctr1 with HA inserted after the 119th
amino acid (Ctr1–3HA) was fully functional in both comple-
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mentation of the growth defects of ⌬ctr1 cells on YPEG media
(Fig. 3A, lower panel) and 64Cu uptake (Fig. 3B) and easily
detectable by Western blotting using anti-HA antibodies (Fig.
3, C and D). No significant difference in growth was observed
on SC media supplemented with toxic copper either (Fig. 3A,
lower panel). Ctr1(300), Ctr1(394), and Ctr1(L397A,L398A)
tagged with HA at the same position were also fully functional
in complementation of cell growth and conferred copper sensitivity (Fig. 3A, lower panel). These data indicate that HA
epitope in the N terminus does not perturb the function and
regulation of Ctr1.
Expression Levels of Ctr1 Possessing Deletion or Site-directed
Mutations at the C Terminus—Copper toxicity in cells expressing Ctr1 possessing a deletion or site-directed mutations in the
C terminus may be attributed to the higher expression levels of
Ctr1 mutants relative to wild type Ctr1. ⌬ctr1 cells expressing
HA epitope-tagged Ctr1 or Ctr1(300) were cultured to mid-log
phase. Cycloheximide (100 g/ml) was added 30 min before
copper supplementation to the culture (0.1 mM CuCl2 for 30
min). Total protein extracts of collected cells were subjected to
Western blot analyses of Ctr1 using anti-HA antibodies. Predicted monomer, dimer, and trimer species were detected, and
expression levels of Ctr1 and Ctr1(300) were similar to each
other (Fig. 3C). Copper supplementation in the culture media
slightly enhanced Ctr1 turnover especially monomer species;
however, no significant difference in protein stability was
observed between Ctr1 and Ctr1(300).
Second, we determined whether the C terminus affects Ctr1
expression levels in cells cultured long term in media containing excess copper. ⌬ctr1 cells expressing empty vector, HAtagged Ctr1, Ctr1(300), Ctr1(394), or Ctr1(L397A,L398A) were
cultured without or with copper supplementation (25 M
CuCl2) in liquid SC media for 12 h. Copper supplementation
results in slow growth of cells expressing Ctr1(300), Ctr1(394),
or Ctr1(L397A,L398A) compared with cells expressing wild
type Ctr1 (data not shown), which is consistent with growth
defects on copper-supplemented solid media. Western blot
analyses of Ctr1 using anti-HA antibodies demonstrated no significant difference in expression levels among these Ctr1 alleles
when cells were cultured in media without copper supplementation (Fig. 3D). However, when cells were cultured in the
media supplemented with copper, expression of Ctr1(300),
Ctr1(394), or Ctr1(L397A,L398A) are lower than wild type Ctr1
(Fig. 3D). Collectively, the differences in the expression levels
do not explain why cells expressing Ctr1 possessing deletion or
mutation at the C terminus are hypersensitive to copper when
compared with cells expressing wild type Ctr1.
C-terminal Truncation Does Not Affect Subcellular Distribution of Ctr1—Although the expression levels of Ctr1 and
Ctr1(300) are similar, the cellular location of Ctr1(300) could be
distinct from Ctr1. To determine subcellular location of HAtagged Ctr1 and Ctr1(300), lysates of cells cultured with or
without supplementation of copper (0.1 mM for 30 min) were
fractionated by a sucrose gradient. Western blot analysis of the
collected fractions showed that Ctr1 is detectable mainly at
high density fractions which were predicted to contain the
plasma membrane (Fig. 4A, left panel). However, copper supplementation to the culture media did not alter subcellular disVOLUME 284 • NUMBER 7 • FEBRUARY 13, 2009
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FIGURE 4. Subcellular distribution of Ctr1 was not altered by C-terminal
deletion or copper in culture media. Triple HA epitopes were inserted into
a NotI site generated by PCR after the 119th amino acid residue of wild type
Ctr1 and Ctr1(300). Cells expressing HA-tagged Ctr1 (HA-Ctr1) (A) or Ctr1(300)
(HA-Ctr1(300)) (B) were cultured without (left panel) or with (right panel) copper supplementation (CuCl2, 0.1 mM) in the growth media for 30 min. Cell
lysates prepared using glass beads were separated on sucrose gradients, and
then portions of collected fractions (0.5 ml each, fractions 1–18 from the top)
were subjected to Western blotting using anti-HA antibodies. Fractions used
for Western blotting are indicated in each figure.

tribution of Ctr1 (Fig. 4A, right panel). No significant difference
in the distribution pattern between Ctr1 (Fig. 4A) and
Ctr1(300) was observed (Fig. 4B) either. These data indicate
that the copper hypersensitivity of cells expressing Ctr1(300) is
not attributed to a different pattern of subcellular distribution
of Ctr1(300) when compared with that of Ctr1.
Cells Defective in Endocytosis Pathway Are Not Hypersensitive to Copper—Because our data were inconsistent with previous reports (24, 25) suggesting copper-responsive internalization and degradation of yeast Ctr1 and the proposed role for
dileucine motif in regulation of subcellular trafficking of plasma
membrane proteins of mammalian cells (31), we further investigated the roles for the endocytosis pathways in regulation of
Ctr1-mediated copper transport. If this molecular event plays a
significant role in preventing excess copper transport, expression of Ctr1 in cells defective of endocytosis pathways would
lead to hypersensitivity to copper in these cells as compared
with isogenic wild type control cells. Consistently, if Ctr1 endocytosis is dependent on the C terminus of Ctr1, wild type strains
expressing C terminus-deleted Ctr1(300) would manifest the
similar copper sensitivity to the endocytosis-defective strains
expressing full-length Ctr1. Yeast strains possessing a temperature-sensitive allele of End4 or Chc1 (end4-1 or chc1-1) are
defective in the internalization of cell surface proteins when
cells are cultured at a restrictive temperature (36, 37). These
strains were transformed with Ctr1 and Ctr1(300) expression
constructs, cultured in permissive temperature (25 °C), and
then shifted to a restrictive temperature (37 °C) to inactivate
End4 or Chc1. Copper (CuCl2) was supplemented into the culture media at concentrations indicated in Fig. 5 for 1 h. Cells
were washed twice, and then diluted cells (100 l, A600 ⫽ 0.001)
were plated on YPD media. Colonies that had grown were
counted after 2 days. ⌬end4 or ⌬chc1 cells expressing wild type
FEBRUARY 13, 2009 • VOLUME 284 • NUMBER 7

FIGURE 5. Copper sensitivity of cells defective in endocytosis or ubiquitination pathways. Wild type Ctr1 or Ctr1 with C-terminal truncation of the
last 106 amino acids (Ctr1(1–300)) were expressed in end4-1 strain (A and B),
chc1-1 strain (C and D), ⌬rsp5 strain (E and F), and isogenic wild type (WT)
control strains. Temperature-sensitive end4-1 and chc1-1 cells and their isogenic control cells were cultured at 25 °C and then shifted to a restrictive
temperature (37 °C) to block endocytosis. ⌬rsp5 and isogenic control strains
were cultured at 30 °C to mid-log phase. Cells were cultured with supplementation of copper (CuCl2) in media at the indicated concentrations for 1 h than
washed twice, and then 100 l of diluted (A600 ⫽ 0.001) cells were plated on
solid YPD media. After incubating plates at 30 °C for 2 days, growing colonies
on plates were counted, and then the colony numbers were compared with
those on control plates where cells precultured without copper were plated.
Each data point indicates the average ⫾ S.D. of at least four independent
assays. *, p ⬍ 0.05; **, p ⬍ 0.01, Student’s t test.

control Ctr1 have slightly higher sensitivity to copper when
compared with their isogenic wild type strains (no statistically
significant difference) (Fig. 5, A and C). However, the wild type
cells and ⌬end4 or ⌬chc1 cells expressing Ctr1(300) were
extremely sensitive to copper. Cells expressing Ctr1(300)
were not able to form colonies after culture in media containing 2 M CuCl2 (Fig. 5, B and D); however, ⬃50% cells
expressing Ctr1 were able to grow after culture in media
containing 500 M CuCl2 (Fig. 5, A and C). These data suggest that the endocytosis pathway does not play a significant
role in the regulation of Ctr1-mediated copper uptake and
that copper sensitivity conferred by Ctr1(300) is not associated with a defect of its internalization in response to excess
copper.
Cells Defective in Rsp5/Npi1 Ubiquitin-protein Ligase Are
Not Hypersensitive to Copper—A recent paper showed that
Ctr1 undergoes Rsp5 ubiquitin-protein ligase-dependent ubiquitination followed by internalization (25). To determine the
roles for the Rsp5/Npi1 ubiquitin ligase in Ctr1-mediated copper transport, we transformed the expression constructs of
Ctr1 and Ctr1(300) into rsp5/npi1 (35) and isogenic wild type
strains. Exponentially growing cells were supplemented with
copper (CuCl2) in culture media at the concentrations indicated in Fig. 5, E and F, for 1 h. Cells were washed twice, and
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FIGURE 6. Determination of the roles for lysine residues (Lys-340 and
-345) within the C terminus of Ctr1 in copper uptake. Full-length Ctr1 or
Ctr1 possessing site-directed mutation of Lys-340 and -345 to arginine
(Ctr1(K340R,K345R) were expressed in a ⌬ctr1 strain. Exponentially growing
cells were diluted (A600 ⫽ 0.1), and then cells (5 l) were spotted on nonfermentable (YPEG) and SC-ura media supplemented with indicated concentrations of copper (CuCl2) or copper chelator BCS. Cell growth was assessed
after 1 and 3 days for SC-ura and YPEG media, respectively.

then diluted cells (100 l, A600 ⫽ 0.001) were plated on YPD
media. Colonies that had grown were counted after 2 days. Colony numbers were lower in the rsp5/npi1 strain (⌬rsp5) when
compared with wild type control cells transformed with the
expression construct of full-length Ctr1, suggesting Rsp5/
Npi1-mediated ubiquitination might play a protective role in
copper toxicity (Fig. 5E). However, both wild type and rsp5/
npi1 cells expressing Ctr1(300) were again extremely sensitive
to copper (Fig. 5F) when compared with the same strains
expressing the full-length wild type Ctr1 (Fig. 5E). These data
suggest that copper sensitivity conferred by Ctr1(300) does not
rely on the defect in Rsp5-mediated ubiquitination of Ctr1 in a
Ctr1 C terminus-dependent manner.
Given a previous report suggesting that Rsp5/Npi1 ubiquitinates two lysine residues in the C terminus (Lys-340 and -345)
(Fig. 2A) (25), we substituted these residues to arginine and
then tested the function and regulation of this Ctr1 allele. ⌬ctr1
cells expressing Ctr1(K340R,K345R) could complement the
Ctr1 deletion on copper requiring YPEG media (Fig. 6), and this
Ctr1 allele did not confer copper hypersensitivity to cells growing on SC media containing excess copper (Fig. 6), which further suggests that defects in ubiquitination of the Lys-340 and
-345 residues are not a reason for copper sensitivity of cells
expressing Ctr1 with a C-terminal deletion. Copper sensitivity
of rsp5/npi1 strain relative to its isogenic wild type strain when
Ctr1 is expressed (Fig. 5E) might reflect an overall poor health
of rsp5/npi1 strain.
Copper Sensitivity Conferred by Ctr1 C-terminal Mutants Is
Dependent on Their Functionality—We next determined
whether hypersensitivity of cells expressing Ctr1 possessing a
deletion or site-directed mutations is associated with excess
copper transport by these mutants. We hypothesized that
deletion of the C terminus in a non-functional Ctr1 does not
confer copper sensitivity if copper transport activities are
necessary for copper sensitivity of cells expressing these Ctr1
mutants. Ctr1 possessing site-directed mutations of conserved Met-127, Met-256, and/or Met-260 to alanine
(Ctr1(M127A) or Ctr1(M256A,M260A)) is non-functional
in copper transport (35). Expression constructs of these Ctr1
mutants with a deletion of the last 106 or 12 amino acids,
Ctr1(300)(M127A), Ctr1(394)(M127A), Ctr1(300)(M256A,
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M260A), and Ctr1(394)(M256A,M260A), were transformed
into a ⌬ctr1 strain. Cell growth on copper-requiring YPEG
media and SC media containing excess copper was examined.
The data presented in Fig. 7A suggest that hypersensitivity to
copper conferred by Ctr1(300) and Ctr1(394) is dependent on
their copper transport activities.
We predicted that Ctr1 containing deletion or site-directed
mutations at the C terminus would transport excess copper.
This hypothesis was tested by determining the 64Cu uptake
kinetics of cells expressing Ctr1(300), Ctr1(394), or
Ctr1(L397A,L398A). ⌬ctr1 cells expressing empty vector, Ctr1,
or Ctr1 mutant alleles were subjected to 64Cu uptake assays
(Fig. 7B). Copper uptake at the concentration of 0.4 M (the
lowest copper concentration) was similar between cells
expressing Ctr1 or Ctr1 mutants; however, the uptake at
more than 2 M copper concentrations was significantly
higher in cells expressing Ctr1 mutants (Fig. 7B, upper
panel). For instance, apparent Vmax of Ctr1(300) for copper
was ⬃4-fold higher than that of full-length Ctr1 (Fig. 7B,
lower panel).
Regulatory Roles for the Cysteine Residues in the C Terminus
of Ctr1—We investigated whether the C terminus plays a role in
copper-responsive control of Ctr1 activities. The conformational changes in the Ctr1 C terminus that are associated with
copper transport (34) might reflect the sensing of intracellular
copper followed by the inhibition of copper translocation. The
C terminus of Ctr1 encompassing the last 106 amino acids possesses five cysteine residues (Cys-304, Cys-310, Cys-312, Cys363, and Cys-365) (Figs. 2A and 8A). To determine the roles of
these cysteine residues in the function and regulation of Ctr1,
we substituted these cysteine residues to serine. These mutants
were expressed in a ⌬ctr1 strain. Cell growth on YPEG media
and SC media supplemented with toxic copper was examined.
Expression of Ctr1 possessing these cysteine mutations complemented the growth defect of ⌬ctr1 cells on YPEG media,
suggesting no significant role of the cysteine residues in
Ctr1-mediated copper transport (Fig. 8B). However, cells
expressing Ctr1(C304S,C310S,C312S) or Ctr1(C363S,
C365S) were hypersensitive to copper (Fig. 8B) on SC-ura
media, suggesting vital roles of these cysteine residues in
blocking excess copper transport.
These Cys residues at the C terminus might bind with copper
when cellular copper is in excess, which could trigger conformational changes followed by inhibition of Ctr1 copper transport activities. To probe the copper binding to the C terminus
of Ctr1, we examined whether expression of C terminus itself in
the cytosol can sequester copper like metallothionein. If copper
ion(s) binds to the C terminus, overexpression of the C termini
in the cytosol would lead to copper resistance in copper sensitive ⌬ace1 cells. Ace1 is a transcription factor that induces
expression of Cup1 and Crs5 metallothionein in response to
excess copper (23). Thus, ⌬ace1 cells are sensitive to copper
toxicity (23). Peptide encompassing the last 125 amino acids of
Ctr1 C terminus (Ctr1(282– 406)) was expressed in a ⌬ace1
strain, and then the cell growth on excess copper media was
monitored. Indeed, expression of the C terminus allowed ⌬ace1
cells to grow on media containing toxic copper (Fig. 8C). However, the same peptide in which cysteine residues are substiVOLUME 284 • NUMBER 7 • FEBRUARY 13, 2009
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FIGURE 8. Determination of the roles of cysteine residues in the C terminus of Ctr1. A, five cysteine residues within the C terminus of Ctr1 encompassing amino acids 301– 406 are indicated. B, full-length Ctr1 or Ctr1 possessing site-directed mutation of cysteine residues within the C terminus
were expressed in a ⌬ctr1 strains. Exponentially growing cells were diluted
(A600 ⫽ 0.1), and then cells (5 l) were spotted on non-fermentable (YPEG) or
SC media supplemented with indicated concentrations of copper (CuCl2) or
copper chelator BCS. Cell growth was assessed after 1 day for SC-ura media
and 3 days for YPEG media. C, C-terminal tail of Ctr1 encompassing the last
124 amino acids (Ctr1(282– 406)) without or with site-directed mutation of
cysteine residues to serine as indicated was expressed in copper-sensitive
⌬ace1 strain. Exponentially growing cells were diluted (A600 ⫽ 0.1), and then
cells (5 l) were spotted on SC media supplemented with indicated concentrations of copper. Cell growth was assessed after 1 day. D, total protein
extracts of cells transformed with expression constructs of the C-terminal
peptides fused with triple HA epitopes in frame were subjected to Western
blotting using anti-HA antibodies.

FIGURE 7. Ctr1 mutants possessing C-terminal deletion transport excess
copper. A, non-functional Ctr1 alleles possessing a C-terminal deletion did
not confer copper sensitivity. Conserved methionine residues (Met-127, Met256, and Met-260) in Ctr1 (30) were substituted with alanine by site-directed
mutagenesis. The last 106 or 12 amino acids in the C terminus were deleted in
these Ctr1 mutants (Ctr1(300) and Ctr1(394), respectively). These mutant Ctr1
alleles were expressed in a ⌬ctr1 strain. Exponentially growing cells were
diluted (A600 ⫽ 0.1), and then cells (5 l) were spotted on non-fermentable
(YPEG) or SC-ura media supplemented with indicated concentrations of copper (CuCl2) or copper chelator BCS. Cell growth was assessed after 1 and 3
days for SC-ura and YPEG media, respectively. B, 64Cu uptake kinetics of cells
expressing Ctr1 with a deletion or site-directed mutations within its C terminus. An empty vector, full-length Ctr1 (Ctr1), or Ctr1 with a deletion of the last
106 or 12 amino acids (Ctr1(300) or Ctr1(394), respectively) or site-directed
mutations of Leu-397 and Leu-398 (Ctr1(L397A,L398A)) within the C terminus
were expressed in a ⌬ctr1 strain. Cells exponentially growing in SC-ura media
were incubated with 64Cu (0.4, 1, 2, 5, 15, or 25 M) for 10 min, and then
cell-associated 64Cu was measured using a ␥ counter. 64Cu uptake was normalized to cell numbers. Each data point represents the average ⫾ S.D. of four
independent assays. Apparent Km (M) and Vmax (pmol/1 ⫻ 107 cells/min) for
copper were calculated.

tuted by serine failed to confer copper resistance (Fig. 8C).
Expression levels of these peptides bearing mutations of cysteine residues were similar to those of the wild type control
peptide (Fig. 8D). These data suggest copper binding to the C
terminus of Ctr1 in a cysteine-dependent mechanism.
Excess Copper in Culture Media Rapidly Inactivates Ctr1mediated Copper Transport in a C Terminus-dependent
Mechanism—We hypothesized that excess copper in media
inhibits Ctr1-mediated copper transport in a C terminus-dependent manner. To test this, we cultured ⌬ctr1 cells transformed with empty vector and expression constructs of Ctr1,
FEBRUARY 13, 2009 • VOLUME 284 • NUMBER 7

Ctr1(300), or Ctr1(394) to mid-log phase with supplementation
of cycloheximide (100 g/ml) for 30 min. The same concentration of cycloheximide was maintained throughout the experiments to prevent new functional Ctr1 synthesis after inactivation of existing Ctr1. Cells were cultured in media
supplemented with copper (CuCl2) at concentrations indicated
in Fig. 9A for 30 min. To determine time-dependent responses
to copper, cells were cultured with 100 M CuCl2 for 1, 5, and 30
min (Fig. 9B). Cells were then washed twice with prewarmed
fresh media, after which 64Cu uptake into cells was measured by
adding 64Cu (0.1 M 64CuCl2) for 5 min to the culture media.
We predicted that if Ctr1 activities are inhibited in response to
excess copper, cells precultured with copper would have a
lower uptake of 64Cu than control cells precultured with no
copper supplementation. Indeed, 64Cu uptake in Ctr1-expressing cells which were precultured with copper (0.1 mM CuCl2 for
30 min) was reduced to less than 20% that of 64Cu uptake in
control cells which received no copper pretreatment (Fig. 9A). 5
or 25 M copper pretreatment for 30 min reduced 64Cu uptake
in cells expressing Ctr1 to 45 or 39% that in control cells which
received no copper pretreatment, respectively (Fig. 9A). This
indicates the copper concentration-dependent inhibition of
Ctr1 activity. Copper (0.1 mM CuCl2) response is fast, as pretreatment for 5 min was sufficient for near maximum inhibition
of 64Cu uptake (Fig. 9B). However, 64Cu uptake into cells
expressing Ctr1(300) or Ctr1(394) and were precultured with
copper (0.1 mM CuCl2 for 30 min) was ⬃46 or 68% that in the
control cells which received no copper pretreatment, respecJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 9. Ctr1-mediated 64Cu uptake in cells precultured in media supplemented with copper. Empty vector, Ctr1, and Ctr1 with a C-terminal deletion of the last 106 or 12 amino acids (Ctr1(300) or Ctr1(394)) were expressed in
a ⌬ctr1 strain. Cells grown to exponential phase in SC-ura media were cultured with cycloheximide (100 mg/ml media) for 30 min, and the same concentration of cycloheximide was maintained throughout experiments to
inhibit new Ctr1 synthesis. Copper (0, 5, 25, or 100 M CuCl2) was added
to culture media for 30 min (A), or copper (0 or 100 M CuCl2) was added to
culture media for 1, 5, or 30 min (B). Cells were washed twice using prewarmed fresh SC media and then resuspended in the same media. To measure 64Cu uptake in these cells, cells were incubated with 64Cu (0.1 M 64CuCl2)
for 5 min and washed twice with PBS containing 10 mM EDTA. Cell-associated
64
Cu was measured using a ␥ counter and normalized to cell numbers. 64Cu
uptake in cells expressing an empty vector was subtracted as background
uptake. Data were presented as percentage (%) of 64Cu uptake in control cells
that were precultured without copper supplementation in media. Each data
point represents the average ⫾ S.D. of at least four independent assays.

tively (Fig. 9A). Indeed, all data points of 64Cu uptake in cells
expressing Ctr1(300) and Ctr1(394) are significantly higher
than those of Ctr1 (p ⬍ 0.001, Student’s t test) (Fig. 9, A and B),
indicating the roles for the Ctr1 C terminus in control of Ctr1
activities in response to excess copper.

DISCUSSION
Our data suggests that the C terminus of Ctr1 in yeast S. cerevisiae plays a regulatory role in preventing toxic copper transport. In the presence of excess copper, Ctr1 transport activity is
rapidly inhibited. This response to copper is dependent on the
C-terminal cytosolic tail of Ctr1 but not associated with apparent changes in expression levels and subcellular location of
Ctr1. Given that copper is extremely toxic and its levels fluctuate in the environment, down-regulation of Ctr1 expression via
the endocytosis pathway and/or transcriptional control may
not be fast enough for the prevention of toxic accumulations of
copper. Hence, control of Ctr1 activity via direct sensing of
cellular copper provides a mechanism by which cells promptly
inhibit excess copper uptake.
The data presented herein indicate that the C terminus is a
regulatory domain that prevents the toxic accumulation of cop-
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per. We propose that when the C terminus senses excess copper
through direct copper coordination by Cys residues, Ctr1-mediated copper transport is blocked. Thus, the C terminus of
Ctr1 serves as a molecular switch that controls homeostatic
copper uptake. Consistent to a report indicating that the purified C-terminal domain of yeast Ctr1 encompassing last 126
amino acids binds four Cu⫹ ions as a cuprous-thiolate polynuclear cluster (45), we were able to show that overexpression of
the C terminus itself in the cytosol could suppress the copper
sensitivity of ⌬ace1 cells likely by sequestering copper. A caveat
of this experiment was that copper binding at the C terminus
might occur within a trimer complex (34); however, our data
suggest that intermolecular coordination is not necessary for
copper binding to the C terminus. Site-directed mutagenesis
studies also suggest that cysteine residues at the C terminus
serve as copper ligands. Hence, structural perturbation of the C
terminus could result in ablation of the inhibitory role of the C
terminus. This could be a reason why cells expressing Ctr1 with
deletion, epitope-tagging, or site-directed mutation of either
copper-sensing residues or any other residues involved in regulatory function of the C terminus transport excess copper and
are sensitive to copper toxicity.
It is also interesting to note recent reports indicating a regulatory function of metal binding to cytosolic domains of other
metal transporters. The x-ray structure of the Mg2⫹ importer
CorA revealed that the cytoplasmic domain contains magnesium binding sites between monomers that do not appear to be
necessary for a transport function (46, 47). The structures of
another magnesium transporter, MgtA, solved with and without magnesium binding to the cytoplasmic domains indeed
showed the Mg2⫹-dependent movement of the cytosolic
domains, which reorganizes the transmembrane helices (48).
Hence, MgtA-mediated magnesium transport could be controlled by intracellular magnesium concentration. Secondly,
YiiP zinc exporter of E. coli is a homodimer that binds with four
zinc ions per subunit (49). Among the four, two zinc ions bind
in the cytoplasmic domain with a metallochaperone-like fold
(49). It was suggested that zinc binding to the cytosolic domain
of YiiP is necessary for the formation of a functional dimeric
complex, which was proposed as a mechanism by which cells
activate this exporter only when cellular zinc levels are in excess
(20). Our data presented herein and reported previously (34)
suggest that a similar mechanism controls Ctr1-mediated copper uptake in yeast.
We could not observe significant changes in cell surface
expression of Ctr1 in cells cultured in media supplemented
with excess copper, which is contradictory to other reports (24,
25). The underlying reasons of these discrepancies among
experimental data are not known. However, we observed that
Ctr1 in lysates prepared from cells cultured in copper-supplemented media migrates higher than trimer species on SDSPAGE if samples are not thoroughly denatured (data not
shown). Liu et al. (25) also commented on these copper-dependent high molecular weight complexes. This could reduce
Ctr1 species corresponding to trimer, dimer, or monomer that
are detected by immunoblotting, resulting in a misinterpretation of these data as a down-regulation of Ctr1. It is also necessary to note that, whereas we fused triple HA epitopes at the N
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terminus of Ctr1, others used Ctr1 fused with GFP or c-Myc
epitope at the C terminus (24, 25). Because this domain undergoes conformational changes when cells are cultured with copper supplementation (34), the detection efficiency of GFP or
c-Myc epitope tagged at the C terminus under incomplete protein denaturation conditions could be different depending on
copper levels in culture media. Hence, the post-translational
regulations determined by monitoring expression levels and
subcellular location of Ctr1 tagged with GFP or c-Myc at the C
terminus might reflect copper-dependent conformational
changes in Ctr1.
Our genetic analyses did not confirm any significant role for
the endocytosis and degradation pathway in homeostatic copper acquisition. We predicted that cells defective in Rsp5 ubiquitin ligase (21, 35) or molecular factors for endocytosis such as
End4 and Chc1 (36, 37) will be hypersensitive to copper if these
factors are necessary for the down-regulation of Ctr1 as suggested previously (25). Second, if copper hypersensitivity of
cells expressing Ctr1 with deletion or site-directed mutations at
its C terminus is attributed to defects in copper-responsive
down-regulation of Ctr1, cells defective in endocytosis pathway
would manifest a similar sensitivity when wild type Ctr1 or Ctr1
with C-terminal deletion is expressed in these cells. However, in
contrast to this prediction, End4- or Chc1-defective cells are
not more sensitive to copper when compared with their isogenic wild type cells, and these strains expressing Ctr1 with
C-terminal deletion are hypersensitive to copper as compared
with cells where the full-length Ctr1 is expressed. Site-directed
mutation of Lys-340 and Lys-345 to arginine, which abolishes
copper-induced internalization of Ctr1 (25), did not lead to a
significant increase in copper sensitivity to cells expressing this
mutant allele. Collectively, our data suggest that ubiquitination
and endocytosis of Ctr1, if any, play a minor role in the prevention of excess uptake of copper as compared with C terminusmediated control of Ctr1 activity.
Ctr1 family members share similar structural features,
including three transmembrane domains and several potential
copper binding residues (3, 4). Site-directed mutagenesis of
conserved methionine residues of Ctr1 in yeast and humans
suggest that the mechanisms of action among Ctr1 family
members are similar (30). However, the C-terminal cytosolic
tail is distinct in length and amino acid sequence. For example,
the predicted C terminus of yeast Ctr1 and human Ctr1 encompasses the last 125 and 12 amino acid residues of each polypeptide, respectively (3, 30). Despite this difference in length, many
of the family members possess predicted metal binding residues
at the C terminus. For instance, the C-terminal cytosolic tail of
yeast Ctr1 contains five cysteine residues. Our mutational analysis of these residues revealed that they are not necessary for
high affinity copper uptake but play a vital role in the prevention of copper toxicity when cells grow in media containing
excess copper. The presence of potential metal binding residues
at the C terminus of other Ctr1 family members suggests that
the regulatory roles of the C terminus characterized in yeast
may be conserved in this family of proteins. We are currently
testing this hypothesis.
Several amino acid residues within the C terminus play critical roles in the control of Ctr1-mediated copper transport. Our
FEBRUARY 13, 2009 • VOLUME 284 • NUMBER 7

in vivo data suggest that cysteine residues in the C terminus
bind with copper, which could be a copper-sensing mechanism
necessary for subsequent inactivation of Ctr1. However, the
roles for the dileucine motif located within the C terminus in
the prevention of toxic copper transport are not clear yet.
Although a sorting signal in mammalian cells that contains the
dileucine motif has been relatively well characterized (31),
function of this motif in yeast is not elucidated yet. Given that
turnover rates and subcellular distribution of Ctr1 are not significantly altered by copper, copper sensitivity in cells expressing Ctr1 where the dileucine residues are substituted to alanine
is unlikely attributed to the role of this motif in endocytosis and
degradation.
Taken together, our data provide an initial glimpse into how
copper regulates the activities of its own transporter. Characterization of high resolution structures of Ctr1 would provide
direct evidences of structural changes that are associated with
copper sensing by the C terminus followed by inactivation of
Ctr1.
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